VENUS REMEDIES LTD. - 526953 - Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0880 Name of the Signatory :- NehaDesignation :- Company Secretary and Compliance Officer VENUS REMEDIES LTD. - 526953 - Compliance Certificate For The Quarter Ended On 31.03.2020
Compliance Certificate for the quarter ended on 31.03.2020 VENUS REMEDIES LTD. - 526953 - Shareholding for the Period Ended March 31, 2020
Venus Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here VENUS REMEDIES LTD. - 526953 - Closure of Trading Window
Trading Window Closure intimation. VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Resignation of Director
Resignation of Non- Executive Independent Director. VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of financial results. VENUS REMEDIES LTD. - 526953 - Outcome Of Board Meeting
This is to inform you that, the Board of Directors of the Company at its meeting held today inter alia considered and approved Unaudited Financial Results for the quarter ended on 31.12.2019. Meeting concluded at 7.40 pm. Venus Remedies Ltd - 526953 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Board meeting notice. VENUS REMEDIES LTD. - 526953 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On 12/02/2020.
VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2020 ,inter alia, to consider and approve Meeting of the Board of Directors of the Company is scheduled to be held on 12/02/2020 to Consider unaudited financial results for the quarter ended on 31st December, 2019 and any other item with the permission of Chair.